NZ302524A - Dna encoding the c140 receptor, agonists and antagonists therefor and use in assays to detect vascular pressure abnormalities - Google Patents

Dna encoding the c140 receptor, agonists and antagonists therefor and use in assays to detect vascular pressure abnormalities

Info

Publication number
NZ302524A
NZ302524A NZ302524A NZ30252496A NZ302524A NZ 302524 A NZ302524 A NZ 302524A NZ 302524 A NZ302524 A NZ 302524A NZ 30252496 A NZ30252496 A NZ 30252496A NZ 302524 A NZ302524 A NZ 302524A
Authority
NZ
New Zealand
Prior art keywords
agonists
assays
receptor
dna encoding
vascular pressure
Prior art date
Application number
NZ302524A
Inventor
Johan Sundelin
Robert M Scarborough
Original Assignee
Cor Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc filed Critical Cor Therapeutics Inc
Publication of NZ302524A publication Critical patent/NZ302524A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ302524A 1995-01-25 1996-01-25 Dna encoding the c140 receptor, agonists and antagonists therefor and use in assays to detect vascular pressure abnormalities NZ302524A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39030195A 1995-01-25 1995-01-25
PCT/US1996/001179 WO1996023225A1 (en) 1995-01-25 1996-01-25 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor

Publications (1)

Publication Number Publication Date
NZ302524A true NZ302524A (en) 1999-05-28

Family

ID=23541929

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ334998A NZ334998A (en) 1995-01-25 1996-01-25 Use of an agonist or antagonist for inhibiting the expression of a C140 receptor
NZ302524A NZ302524A (en) 1995-01-25 1996-01-25 Dna encoding the c140 receptor, agonists and antagonists therefor and use in assays to detect vascular pressure abnormalities

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NZ334998A NZ334998A (en) 1995-01-25 1996-01-25 Use of an agonist or antagonist for inhibiting the expression of a C140 receptor

Country Status (7)

Country Link
EP (1) EP0870198A4 (en)
JP (1) JPH11514207A (en)
KR (1) KR19980701637A (en)
CA (1) CA2211176A1 (en)
NO (1) NO973422L (en)
NZ (2) NZ334998A (en)
WO (1) WO1996023225A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9620028D0 (en) * 1996-09-26 1996-11-13 Ludwig Inst Cancer Res Factors which interact with oncoproteins
US6737252B2 (en) 1997-07-25 2004-05-18 Schering Corporation 7 transmembrane receptor family member BLRX
US6984719B1 (en) 1998-09-17 2006-01-10 Hospital Sainte-Justine Peptide antagonists of prostaglandin F2α receptor
WO2000017348A1 (en) 1998-09-17 2000-03-30 Hopital Sainte-Justine G protein-coupled receptor agonists or antagonists
AU784630B2 (en) 1999-12-06 2006-05-18 Hopital Sainte-Justine Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
US7214655B2 (en) * 2001-05-21 2007-05-08 Johnson & Johnson Consumer Companies, Inc. Peptides and the use thereof in darkening the skin
US7521530B2 (en) 2002-06-11 2009-04-21 Universite De Montreal Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor
JP4927566B2 (en) 2004-12-28 2012-05-09 興和株式会社 PAR-2 agonist
WO2006104190A1 (en) 2005-03-29 2006-10-05 Kowa Company, Ltd. Par-2 agonist
FR2883873B1 (en) * 2005-03-31 2009-07-10 Pharmamens Sarl AGE INHIBITORS
AR070911A1 (en) * 2008-03-19 2010-05-12 Regeneron Pharma USE OF PARTA RECEPTOR ANTAGONISTS ACTIVATED WITH PROTEASA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629174A (en) * 1993-07-26 1997-05-13 Cor Therapeutics, Inc. Recombinant C140 receptor

Also Published As

Publication number Publication date
JPH11514207A (en) 1999-12-07
NZ334998A (en) 2000-11-24
NO973422D0 (en) 1997-07-24
KR19980701637A (en) 1998-06-25
NO973422L (en) 1997-09-24
EP0870198A1 (en) 1998-10-14
CA2211176A1 (en) 1996-08-01
WO1996023225A1 (en) 1996-08-01
EP0870198A4 (en) 2001-04-04

Similar Documents

Publication Publication Date Title
AU3878697A (en) Identification of abnormalities in the expression of t and cell antigen receptors as indicators of disease diagnosis, prognosis and therapeutic predictors
ZA200007040B (en) Catalyst modifiers and their use in the polymerization of olefin(s).
ZA974234B (en) Adhesion receptor antagonists.
EP0822814A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
EP0998285A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
HUP9801433A3 (en) Glycoprotein iib/iiia antagonists, preparation and use thereof and pharmaceutical composition
ZA9711316B (en) Vitronectin receptor antagonists, their preparation and their use.
NZ302524A (en) Dna encoding the c140 receptor, agonists and antagonists therefor and use in assays to detect vascular pressure abnormalities
GB2329817B (en) Detecting,improving and characterising material in 3-D space
GB9710489D0 (en) Improvements in & relating to monitoring & analysis
HK1020739A1 (en) Novel lantibiotic related to actagardine, and processes for the preparation and use thereof.
EP0981730A4 (en) Liquid level sensor for use in a hot, pressurized liquid
HK1025782A1 (en) 1:2chromium complex dyes, the production and use thereof
ZA9711456B (en) VEGF-B/receptor complex and uses thereof.
NZ315846A (en) Endothelin receptor antagonists, in particular, substituted pyrazol-4-yl-substituted-prop-2-enoic acid derivatives
EP1100009A3 (en) Liaison interface
EP0831824A4 (en) ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
AU762275C (en) An upper saddle for use in an elevated cableway system
ITBO950119A0 (en) MIXER, PARTICULARLY FOR THE BUILDING INDUSTRY
GB2328753B (en) Improvements in or relating to fluid flow measurement
DE29709179U1 (en) Form gauge in composite design
GB9715612D0 (en) Improvements in or realting to equestrian equipment or the line
AU7036498A (en) Linear alternating functionalized alpha-olefin/co-copolymers and their use in preparing ion-selective membranes
DE29610601U1 (en) Accessible connecting element between multi-purpose containers arranged on different floors
GB9720401D0 (en) Safety device for use in roofing operations or the like